Abcodia Ltd

Abcodia Ltd is a biomarker company focussing on the validation of molecular biomarkers for disease diagnosis and personalised medicine. At the heart of the company is a unique biobank, the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) founded in 2001 and led by clinical scientists at UCL. UKCTOCS is the world’s largest prospective study for ovarian cancer diagnosis and will result in the generation of a collection of more than 5 million high quality serum aliquots (UKCTOCS sample bank), associated with clinical demographic and age-related disease phenotypic data from over 200,000 women across the UK. A wide range of diseases are now recorded across this aging cohort, making it amenable to the discovery of biomarkers and screening diagnostics for several therapeutic areas.

Year founded

2010

Abcodia.com